Representative before the EPO

Company dna fry heath and spence llp
no operation time available
3 offices
active in Legal Services

We have observed 25 EP applications Michèle E. Richards has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 16, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12709175

ANTIVIRAL COMPOSITION

IPC classification:
A61K 36/60, A61P 31/22
Agent:
Michèle E. Richards, Fry Heath & Spence LLP
Status:
GRANT OF PATENT INTENDED
EP12723912

A CRYSTALLINE FORM OF A SALT OF A MORPHOLINO SULFONYL INDOLE DERIVATIVE AND A PROCESS FOR ITS PREPARATION

IPC classification:
A61K 31/5377, A61P 35/00, C07D 413/14
Agent:
Michèle E. Richards, Fry Heath & Spence LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12738184

A SYNERGISTIC PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF SQUAMOUS CELL CARCINOMA OF HEAD AND NECK

IPC classification:
A61K 31/337, A61K 31/4025, A61K 31/4412, A61K 31/513, A61K 31/517, A61K 33/24, A61K 39/395, A61P 35/00
Agent:
Michèle E. Richards, Fry Heath & Spence LLP
Status:
GRANT OF PATENT INTENDED
EP11719887

CYTOKINE INHIBITORS

IPC classification:
A61K 31/40, A61P 29/00, C07D 207/08, C07D 257/04, C07D 401/10, C07D 405/10
Agent:
Michèle E. Richards, Fry Heath & Spence LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13705838

PYRROLIDINE- SUBSTITUTED FLAVONE DERIVATIVES FOR PREVENTION OR TREATMENT OF ORAL MUCOSITIS

IPC classification:
A61K 31/4025, A61P 17/16
Agent:
Michèle E. Richards, Fry Heath & Spence LLP
Status:
PATENT GRANTED
EP11713049

OXADIAZOLE COMPOUNDS, THEIR PREPARATION AND USE

IPC classification:
A61K 31/4245, A61P 35/02, C07D 271/06, C07D 413/06
Agent:
Michèle E. Richards, Fry Heath & Spence LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13752547

AN IMPROVED PROCESS FOR THE PREPARATION OF APREPITANT

IPC classification:
A61K 31/5377, C07D 265/32, C07D 413/06
Agent:
Michèle E. Richards, Fry Heath & Spence LLP
Status:
PATENT GRANTED
EP13719305

PHENYL ALKANOIC ACID DERIVATIVES AS GPR AGONISTS

IPC classification:
A61K 31/192, A61P 3/10, A61P 9/00, C07D 305/06, C07D 307/08, C07D 335/02, C07D 405/12
Agent:
Michèle E. Richards, Fry Heath & Spence LLP
Status:
EXAMINATION IN PROGRESS
EP13761439

HERBAL COMPOSITION FOR THE TREATMENT OF METABOLIC DISORDERS

IPC classification:
A61K 36/00, A61P 3/04, A61P 3/10
Agent:
Michèle E. Richards, Fry Heath & Spence LLP
Status:
EXAMINATION IN PROGRESS
EP13781126

COMPOSITION FOR TREATING METABOLIC DISORDERS

IPC classification:
A61K 36/18, A61P 3/00
Agent:
Michèle E. Richards, Fry Heath & Spence LLP
Status:
GRANT OF PATENT INTENDED
EP13787676

HEXADEPSIPEPTIDE ANALOGUES AS ANTICANCER COMPOUNDS

IPC classification:
A61K 38/15, A61P 35/00, C07K 11/02
Agent:
Michèle E. Richards, Fry Heath & Spence LLP
Status:
GRANT OF PATENT INTENDED
EP12851993

A PROCESS FOR THE PREPARATION OF VALACYCLOVIR HYDROCHLORIDE

IPC classification:
C07D 473/18
Agent:
Michèle E. Richards, Fry Heath & Spence LLP
Status:
GRANT OF PATENT INTENDED
EP11725808

NITRIC OXIDE RELEASING PRODRUGS OF THERAPEUTIC AGENTS

IPC classification:
A61K 31/21, A61P 9/00, A61P 29/00, C07C 203/04, C07C 229/42, C07C 233/25, C07C 233/63, C07C 317/18, C07C 323/12, C07D 207/34, C07D 209/28, C07D 209/52, C07D 211/90, C07D 213/80, C07D 223/22
Agent:
Michèle E. Richards, Fry Heath & Spence LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13845500

AN IMPROVED PROCESS FOR PREPARATION OF PERINDOPRIL INTERMEDIATE

IPC classification:
C07D 209/42
Agent:
Michèle E. Richards, Fry Heath & Spence LLP
Status:
Grant of patent is intended
EP11805197

PHARMACEUTICAL COMBINATION OF PACLITAXEL AND A CDK INHIBITOR

IPC classification:
A61K 31/337, A61K 31/4025, A61P 35/00
Agent:
Michèle E. Richards, Fry Heath & Spence LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP10710637

PYRROLIDINE SUBSTITUTED FLAVONES FOR THE TREATMENT OF INFLAMMATORY DISORDERS

IPC classification:
A61K 31/4025, A61P 1/00, A61P 9/00, A61P 11/00, A61P 17/00, A61P 29/00, C07D 405/04, C07D 409/04
Agent:
Michèle E. Richards, Fry Heath & Spence LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11808341

SUBSTITUTED IMIDAZOQUINOLINE DERIVATIVES

IPC classification:
A61K 31/4745, A61P 29/00, C07D 471/04
Agent:
Michèle E. Richards, Fry Heath & Spence LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11748466

SUBSTITUTED IMIDAZOQUINOLINE DERIVATIVES AS KINASE INHIBITORS

IPC classification:
A61K 31/4745, A61P 35/00, C07D 471/02
Agent:
Michèle E. Richards, Fry Heath & Spence LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11757941

MICROPARTICLE FORMULATION FOR PULMONARY DRUG DELIVERY OF ANTI-INFECTIVE MOLECULE FOR TREATMENT OF INFECTIOUS DISEASES

IPC classification:
A61K 9/16, A61K 31/4748, A61P 31/04, A61P 31/06
Agent:
Michèle E. Richards, Fry Heath & Spence LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14857459

HERBAL COMPOSITION, PROCESS FOR ITS PREPARATION AND USE THEREOF

IPC classification:
A61K 36/42, A61P 3/10
Agent:
Michèle E. Richards, Fry Heath & Spence LLP
Status:
EXAMINATION REQUESTED
EP14879353

AN IMPROVED PROCESS FOR THE PREPARATION OF TRAZODONE AND HYDROCHLORIDE SALT THEREOF

IPC classification:
C07C 39/06, C07C 211/63, C07D 295/06, C07D 471/04
Agent:
Michèle E. Richards, Fry Heath & Spence LLP
Status:
EXAMINATION REQUESTED
EP17162282

A COMPOSITION FOR USE IN CELL THERAPY AND METHODS FOR ITS PREPARATION

IPC classification:
A61K 35/14, C12N 5/0783
Agent:
Michèle E. Richards, Fry Heath & Spence LLP
Status:
The application has been published
EP15851026

STABLE INJECTABLE COMPOSITION OF PHARMACEUTICALLY ACTIVE AGENTS AND PROCESS FOR ITS PREPARATION

IPC classification:
A61K 9/08, A61K 31/675, A61K 38/12, A61K 38/49, A61P 31/00, A61P 35/00
Agent:
Michèle E. Richards, Fry Heath & Spence LLP
Status:
Request for examination was made
EP15850857

STABLE INJECTABLE COMPOSITION OF BIVALIRUDIN AND PROCESS FOR ITS PREPARATION

IPC classification:
A61K 9/08, A61K 38/10, A61P 7/02
Agent:
Michèle E. Richards, Fry Heath & Spence LLP
Status:
Request for examination was made
EP16734947

AN IMPROVED PROCESS FOR THE PREPARATION OF LURASIDONE AND ITS INTERMEDIATE

IPC classification:
C07D 417/14, C07D 487/10
Agent:
Michèle E. Richards, Fry Heath & Spence LLP
Status:
Request for examination was made

Please Sign in to use this feature